Research
Research for a Better Tomorrow
Scleroderma Atlantic is devoted to supporting the research efforts that improve care and get us closer to a cure.
As part of our mission, Scleroderma Atlantic is honoured to award research funding that prioritizes a brighter future for the scleroderma community.
The Research Fund
The Scleroderma Atlantic Research Fund is part of our ongoing efforts to encourage and contribute to research initiatives that will benefit those living with scleroderma. This fund supports scientific research that can lead to improvements in the understanding, treatment, and management of scleroderma.
This initiative reflects Scleroderma Atlantic’s long-standing commitment to supporting scientific advancements. It builds on our history of funding research projects, such as our support for the Scleroderma Patient-centered Intervention Network (SPIN).
By investing in research, the fund will enable graduate students, researchers, and institutions to explore the most pressing questions in scleroderma science. Research supported by the fund may include, but is not limited to:
- Investigations into the underlying causes and mechanisms of scleroderma
- Clinical trials exploring potential new treatments or therapies
- Studies focused on improving the quality of life and symptom management
- Research on early diagnosis and disease progression
- Projects that explore mental health impacts, fatigue, and pain associated with scleroderma
- Health services research that seeks to improve care delivery and accessibility
By supporting a wide range of scientific inquiries, this fund aims to foster discoveries that can bring real change to the lives of people affected by this complex and rare disease.
Funding Policy & Procedures
Eligibility Criteria
- Applicants must be based in Canada.
- Eligible institutions include universities, affiliated research centres, teaching hospitals, and health care institutes.
- Graduate and doctoral students conducting research under academic supervision are welcome to apply.
- Research must have a clear and direct relevance to scleroderma.
Funding Scope
- Grants of up to $5,000 per year may be awarded, subject to the availability of funds
- Funding is conditional on submission of a final report.
- Grant recipients may be asked to present their research findings at various events.
Assessment Criteria
- Scientific merit and innovation
- Relevance to the scleroderma community
- Feasibility and methodology
- Ability to clearly communicate findings to the general population to improve patient support, enhance care practices, and effectively advocate.
Application Process
How To Apply?
Email completed applications and supporting documents to: info@sclerodermaatlantic.ca
All submissions will be reviewed by the Research Advisory Committee, with recommendations made to the Scleroderma Atlantic Board of Directors for final approval.
